Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Nicotine Replacement Therapy Market: By Product: Nicotine Replacement Therapy (NRT), E-cigarettes, Heat-not-burn Tobacco Products; By Distribution Channel: Offline, Online; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Nicotine Replacement Therapy Market Outlook

The global nicotine replacement therapy market attained a value of more than USD 44.7 billion in 2021. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 16.36% to reach above USD 109.2 billion by 2027.

 

Rising Awareness Regarding the Health-Related Issues of Cigarettes Aiding the Market for Nicotine Replacement Therapy

The market for nicotine replacement therapy is being aided by the rising prevalence of health-related issues associated with cigarette smoking. Moreover, the increasing cardiovascular diseases related to nicotine consumption is surging the demand for nicotine replacement therapy. The growing use of nicotine chewing gum as a substitute for oral nicotine activities is driving the market for nicotine replacement therapy. As the awareness regarding the harmful effects of nicotine is increasing the demand for nicotine replacement therapy, the market is witnessing robust growth.

 

Global Nicotine Replacement Therapy Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The increasing innovations to develop nicotine gums with enhanced taste is significantly contributing to the growth of the market. The growing use of nicotine gums to regulate and control nicotine intake is propelling the growth of the market. Moreover, the development of nicotine gums with innovative flavours like cinnamon, mint, and fruit, among others, to enhance their sensory appeal is positively impacting the market growth of nicotine replacement therapy.

 

Nicotine Replacement Therapy: Industry Definition and Segmentation

Nicotine replacement therapy is a treatment that aids people quit the consumption of tobacco and nicotine. The products used in nicotine replacement therapy do not contain harmful toxins found in tobacco. As the sudden halt of nicotine intake leads to withdrawal symptoms, nicotine replacement therapy is used to reduce such symptoms.

The major products of nicotine replacement therapy are:

  • Nicotine Replacement Therapy (NRT)
  • E-cigarettes
  • Heat-not-burn Tobacco Products

Nicotine replacement therapy (NRT) is further divided into inhalers, gum, transdermal patches, sublingual tablets, and lozenges, among others.

The market can be broadly categorised on the basis of its distribution channels into:

  • Offline
  • Online

The EMR report looks into the regional markets of nicotine replacement therapy like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Increasing Use of E-Cigarettes as a Nicotine Replacement Therapy to Drive the Market Growth

As e-cigarettes do not expose smokers to harmful gases, they do not result in health-related issues as compared to traditional cigarettes. This is surging their use as a nicotine replacement therapy, especially in developed countries, which is propelling the growth of the market. In addition, the availability of diverse devices for vaping is providing a personalised smoking experience to cigarette smokers to aid them in quitting, which is significantly contributing to the market for nicotine replacement therapy.

The development of innovative e-cigarettes that meet public health standards is expected to drive the market growth.  The increasing approval of sales and marketing of e-cigarettes by health authorities to reduce the dependency on traditional cigarettes is anticipated to fuel the market growth of the nicotine replacement therapy. For instance, in October 2021, the Food and Drug Administration (FDA) of the United States approved the sale and marketing of the e-cigarettes brand, Vuse, for the first time. Furthermore, the initiation of various research and development (R&D) activities to determine the effectiveness of e-cigarette as a nicotine replacement therapy is projected to propel the market growth in the forecast period.

 

Key Industry Players in the Global Nicotine Replacement Therapy Market

The report presents a detailed analysis of the following key players in the global nicotine replacement therapy market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Cipla Inc.
  • Pfizer Inc.
  • Glenmark Pharmaceuticals Limited
  • Fertin Pharma A/S
  • Philip Morris International Inc.
  • British American Tobacco plc
  • Imperial Brands plc
  • Japan Tobacco Inc.
  • Johnson and Johnson Private Limited
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and
Forecast Market Analysis by Segment- Product, Distribution Channel, Region
Breakup by Product Nicotine Replacement Therapy (NRT), E-cigarettes, Heat-not-burn Tobacco Products
Breakup by Distribution Channel Offline, Online
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Cipla Inc., Pfizer Inc., Glenmark Pharmaceuticals Limited, Fertin Pharma A/S,
Philip Morris International Inc., British American Tobacco plc, Imperial Brands plc,
Japan Tobacco Inc., Johnson and Johnson Private Limited, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Nicotine Replacement Therapy Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Nicotine Replacement Therapy Historical Market (2017-2021) 
    8.3    Global Nicotine Replacement Therapy Market Forecast (2022-2027)
    8.4    Global Nicotine Replacement Therapy Market by Product
        8.4.1    Nicotine Replacement Therapy (NRT)
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
            8.4.1.4    Breakup by Type
                8.4.1.4.1    Inhalers
                8.4.1.4.2    Gum
                8.4.1.4.3    Transdermal Patches
                8.4.1.4.4    Sublingual Tablets
                8.4.1.4.5    Lozenges 
                8.4.1.4.6    Others
        8.4.2    E-cigarettes
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Heat-not-burn Tobacco Products
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
    8.5    Global Nicotine Replacement Therapy Market by Distribution Channel
        8.5.1    Offline
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Online
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
    8.6    Global Nicotine Replacement Therapy Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Cipla Inc.
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Pfizer Inc.
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Glenmark Pharmaceuticals Limited
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Fertin Pharma A/S
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    Philip Morris International Inc.
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    British American Tobacco plc
            11.2.6.1    Company Overview
            11.2.6.2    Product Portfolio
            11.2.6.3    Demographic Reach and Achievements
            11.2.6.4    Certifications
        11.2.7    Imperial Brands plc
            11.2.7.1    Company Overview
            11.2.7.2    Product Portfolio
            11.2.7.3    Demographic Reach and Achievements
            11.2.7.4    Certifications
        11.2.8    Japan Tobacco Inc.
            11.2.8.1    Company Overview
            11.2.8.2    Product Portfolio
            11.2.8.3    Demographic Reach and Achievements
            11.2.8.4    Certifications
        11.2.9    Johnson and Johnson Private Limited
            11.2.9.1    Company Overview
            11.2.9.2    Product Portfolio
            11.2.9.3    Demographic Reach and Achievements
            11.2.9.4    Certifications
        11.2.10    Others
12    Industry Events and Developments

 

List of Figures and Tables

1.    Global Nicotine Replacement Therapy Market: Key Industry Highlights, 2017 and 2027
2.    Global Nicotine Replacement Therapy Historical Market: Breakup by Product (USD Billion), 2017-2021
3.    Global Nicotine Replacement Therapy Market Forecast: Breakup by Product (USD Billion), 2022-2027
4.    Global Nicotine Replacement Therapy Historical Market: Breakup by Distribution Channel (USD Billion), 2017-2021
5.    Global Nicotine Replacement Therapy Market Forecast: Breakup by Distribution Channel (USD Billion), 2022-2027
6.    Global Nicotine Replacement Therapy Historical Market: Breakup by Region (USD Billion), 2017-2021
7.    Global Nicotine Replacement Therapy Market Forecast: Breakup by Region (USD Billion), 2022-2027
8.    North America Nicotine Replacement Therapy Historical Market: Breakup by Country (USD Billion), 2017-2021
9.    North America Nicotine Replacement Therapy Market Forecast: Breakup by Country (USD Billion), 2022-2027
10.    Europe Nicotine Replacement Therapy Historical Market: Breakup by Country (USD Billion), 2017-2021
11.    Europe Nicotine Replacement Therapy Market Forecast: Breakup by Country (USD Billion), 2022-2027
12.    Asia Pacific Nicotine Replacement Therapy Historical Market: Breakup by Country (USD Billion), 2017-2021
13.    Asia Pacific Nicotine Replacement Therapy Market Forecast: Breakup by Country (USD Billion), 2022-2027
14.    Latin America Nicotine Replacement Therapy Historical Market: Breakup by Country (USD Billion), 2017-2021
15.    Latin America Nicotine Replacement Therapy Market Forecast: Breakup by Country (USD Billion), 2022-2027
16.    Middle East and Africa Nicotine Replacement Therapy Historical Market: Breakup by Country (USD Billion), 2017-2021
17.    Middle East and Africa Nicotine Replacement Therapy Market Forecast: Breakup by Country (USD Billion), 2022-2027
18.    Global Nicotine Replacement Therapy Market Structure

Key Questions Answered in the Report

In 2021, the global nicotine replacement therapy market attained a value of nearly more than USD 44.7 billion.

The market is projected to grow at a CAGR of 16.36% between 2022 and 2027.

The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach above USD 109.2 billion by 2027.

The market is being aided by the growing prevalence of health-related issues associated with cigarette smoking and the development of innovative nicotine gums.

The industry is expected to be augmented by the growing use of e-cigarettes, the availability of diverse devices for vaping, and the increasing approvals of e-cigarettes.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major products of nicotine replacement therapy in the industry are nicotine replacement therapy (NRT), e-cigarettes, and heat-not-burn tobacco products.

The significant distribution channels in the market are online and offline.

The major players in the industry are Cipla Inc., Pfizer Inc., Glenmark Pharmaceuticals Limited, Fertin Pharma A/S, Philip Morris International Inc., British American Tobacco plc, Imperial Brands plc, Japan Tobacco Inc., and Johnson and Johnson Private Limited, among others.

Analyst Review

The global nicotine replacement therapy market attained a value of more than USD 44.7 billion in 2021, driven by the growing prevalence of health-related issues associated with cigarette smoking. Aided by the growing use of e-cigarettes, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 16.36%. The market is projected to reach above USD 109.2 billion by 2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its products, the nicotine replacement therapy industry can be segmented into nicotine replacement therapy (NRT), e-cigarettes, and heat-not-burn tobacco products. On the basis of distribution channels, the industry is divided into online and offline. The major regional markets for nicotine replacement therapy are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Cipla Inc., Pfizer Inc., Glenmark Pharmaceuticals Limited, Fertin Pharma A/S, Philip Morris International Inc., British American Tobacco plc, Imperial Brands plc, Japan Tobacco Inc., and Johnson and Johnson Private Limited, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER